Scientific Research An Academic Publisher
OPEN ACCESS
Add your e-mail address to receive free newsletters from SCIRP.
Select Journal AA AAD AAR AASoci AAST ABB ABC ABCR ACES ACS ACT AD ADR AE AER AHS AID AiM AIT AJAC AJC AJCC AJCM AJIBM AJMB AJOR AJPS ALAMT ALC ALS AM AMI AMPC ANP APD APE APM ARS ARSci AS ASM BLR CC CE CellBio ChnStd CM CMB CN CRCM CS CSTA CUS CWEEE Detection EMAE ENG EPE ETSN FMAR FNS GEP GIS GM Graphene GSC Health IB ICA IIM IJAA IJAMSC IJCCE IJCM IJCNS IJG IJIDS IJIS IJMNTA IJMPCERO IJNM IJOC IJOHNS InfraMatics JACEN JAMP JASMI JBBS JBCPR JBiSE JBM JBNB JBPC JCC JCDSA JCPT JCT JDAIP JDM JEAS JECTC JEMAA JEP JFCMV JFRM JGIS JHEPGC JHRSS JIBTVA JILSA JIS JMF JMGBND JMMCE JMP JPEE JQIS JSBS JSEA JSEMAT JSIP JSS JSSM JST JTR JTST JTTs JWARP LCE MC ME MI MME MNSMS MPS MR MRC MRI MSA MSCE NJGC NM NR NS OALib OALibJ ODEM OJA OJAB OJAcct OJAnes OJAP OJApo OJAppS OJAPr OJAS OJBD OJBIPHY OJBM OJC OJCB OJCD OJCE OJCM OJD OJDer OJDM OJE OJEE OJEM OJEMD OJEpi OJER OJF OJFD OJG OJGas OJGen OJI OJIC OJIM OJINM OJL OJM OJMC OJMetal OJMH OJMI OJMIP OJML OJMM OJMN OJMP OJMS OJMSi OJN OJNeph OJO OJOG OJOGas OJOp OJOph OJOPM OJOTS OJPathology OJPC OJPChem OJPed OJPM OJPP OJPS OJPsych OJRA OJRad OJRD OJRM OJS OJSS OJSST OJST OJSTA OJTR OJTS OJU OJVM OPJ POS PP PST PSYCH SAR SCD SGRE SM SN SNL Soft SS TEL TI UOAJ VP WET WJA WJCD WJCMP WJCS WJET WJM WJNS WJNSE WJNST WJV WSN YM
More>>
Coumadin [Prescribing Information] (2011) Bristol-Myers Squibb Company, Princeton.
has been cited by the following article:
TITLE: Novel Therapeutic Options for the Treatment of Nonvalvular Atrial Fibrillation
AUTHORS: Rupal Patel Mansukhani, Lucio R. Volino
KEYWORDS: Atrial Fibrillation, Dabigatran, Rivaroxaban, Apixiaban
JOURNAL NAME: Pharmacology & Pharmacy, Vol.5 No.11, October 29, 2014
ABSTRACT: Objective: To review the literature for the emerging oral anticoagulants, dabigatran, rivaroxaban, and apixaban currently available in the United States. Data Source: A literature review was performed in MEDLINE (1947–July 2014) using the keywords atrial fibrillation AND dabigatran OR rivaroxaban OR apixaban. The references identified from the literature review were then evaluated. All of the literature retrieved from MEDLINE that was published as an original clinical trial was included in this review. Other pertinent articles published related to the original clinical trials were also considered. The references included in this review were limited to studies conducted in humans and written in the English language. Conclusion: The new oral anticoagulant agents have demonstrated benefit over warfarin. The pharmacologic profiles of the newer agents are predictable, with rapid onsets of action. The newer agents are also more convenient for patients since they do not require regular INR monitoring. Although there are many advantages to the newer agents, a patient evaluation must be considered prior to initiating them.
Related Articles:
Research on GF Company Training System
Mingyue Gao
DOI: 10.4236/jhrss.2017.53014 635 Downloads 1,135 Views Citations
Pub. Date: September 8, 2017
Proteomic progress in studying tuberculosis from 2010 to 2011
Lijun Zhang, Douglas Lowrie, Honghao Zhou
DOI: 10.4236/jbpc.2011.24045 5,149 Downloads 9,275 Views Citations
Pub. Date: November 9, 2011
Measles in a Neonatal Unit during Epidemic Period in 2011
Josefina Marquez, Laura Acosta, Manuel Fernandez
DOI: 10.4236/aid.2012.24020 3,794 Downloads 6,253 Views Citations
Pub. Date: December 13, 2012
The Transformation of Japanese Street Fashion between 2006 and 2011
Aliyaapon Jiratanatiteenun, Chiyomi Mizutani, Saori Kitaguchi, Tetsuya Sato, Kanji Kajiwara
DOI: 10.4236/aasoci.2012.24038 8,321 Downloads 17,283 Views Citations
Pub. Date: December 25, 2012
An Appraisal of Gender Mainstreaming in Census of India 2011
Mohmad Saleem Jahangir, Aneesa Shafi
DOI: 10.4236/aasoci.2013.35029 4,185 Downloads 5,853 Views Citations
Pub. Date: August 30, 2013